We are live on ! Find out more
HCAT icon

Health Catalyst

1.31 USD
+0.02
1.55%
At close Updated Nov 20, 4:00 PM EST
1 day
1.55%
5 days
-12.08%
1 month
-25.14%
3 months
-19.63%
6 months
1.55%
Year to date
-42.54%
1 year
-35.47%
5 years
-97.12%
10 years
-96.66%
 

About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Employees: 1,200

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 30%
Neutral 70%
Negative 0%
Neutral
Seeking Alpha
15 days ago
Health Catalyst, Inc. (HCAT) Q3 2026 Earnings Call Transcript
Health Catalyst, Inc. ( HCAT ) Q3 2026 Earnings Call November 5, 2026 5:00 PM EST Company Participants Stephanie St Clair - Senior Vice President of Finance & Investor Relations Simeon Kohl - CEO, President, Principal Executive & Operating Officer and Director Jason Alger - Chief Financial Officer Presentation Operator Welcome to the Health Catalyst Third Quarter 2026 Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Stephanie St. Clair, Senior Vice President of Finance and Investor Relations.
Health Catalyst, Inc. (HCAT) Q3 2026 Earnings Call Transcript
Positive
MarketBeat
16 days ago
What Health Catalyst (HCAT) Said on Its Q3 Earnings Call
Health Catalyst NASDAQ: HCAT reported third-quarter revenue and adjusted EBITDA above its guidance ranges, but executives said client churn and cost pressures remain challenges as the healthcare technology company works to improve profitability.
What Health Catalyst (HCAT) Said on Its Q3 Earnings Call
Positive
Zacks Investment Research
16 days ago
Health Catalyst (HCAT) Reports Q3 Loss, Beats Revenue Estimates
Health Catalyst (HCAT) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.06 per share a year ago.
Health Catalyst (HCAT) Reports Q3 Loss, Beats Revenue Estimates
Positive
Zacks Investment Research
16 days ago
Here's What Key Metrics Tell Us About Health Catalyst (HCAT) Q3 Earnings
While the top- and bottom-line numbers for Health Catalyst (HCAT) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here's What Key Metrics Tell Us About Health Catalyst (HCAT) Q3 Earnings
Neutral
GlobeNewsWire
16 days ago
Health Catalyst Reports Third Quarter 2026 Results
SALT LAKE CITY, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended September 30, 2026.
Health Catalyst Reports Third Quarter 2026 Results
Neutral
GlobeNewsWire
1 month ago
Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026
SALT LAKE CITY, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its third quarter 2026 operating results on Thursday, November 5, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026
Neutral
GlobeNewsWire
2 months ago
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SALT LAKE CITY, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that on September 14, 2026, the Compensation Committee of the Company's Board of Directors granted 2,747,385 restricted stock units (the “RSUs”) to Simeon Kohl under the Health Catalyst, Inc. 2026 Employment Inducement Incentive Plan (the “Inducement Plan”) in connection with Mr. Kohl's previously announced appointment as Chief Executive Officer and President of the Company effective on September 14, 2026. The awards were granted as inducement material to Mr. Kohl's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Neutral
PRNewsWire
2 months ago
Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
Reller Joins Health Catalyst as it Enters Its Next Phase of Growth SALT LAKE CITY, Sept. 14, 2026 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst", NASDAQ: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Tami Reller has been appointed to its board of directors (Board), effective October 1, 2026.
Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
Neutral
GlobeNewsWire
2 months ago
Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
SALT LAKE CITY, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Simeon Kohl has been appointed Chief Executive Officer (CEO) and President and a member of the Company's Board of Directors, effective September 14, 2026.
Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
Neutral
GlobeNewsWire
2 months ago
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the 2026 Wells Fargo Healthcare Conference, taking place in Boston, on Wednesday, September 9, 2026 and Thursday, September 10, 2026.
Health Catalyst to Participate in Upcoming Investor Conference
Price charts implemented using Lightweight Charts™